Dr. Stoller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 N Village Ave
Ste 402
Rockville Centre, NY 11570Phone+1 516-766-2519Fax+1 516-766-3714
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Ophthalmology, 1992 - 1995
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1990 - 1992
New York University School of MedicineClass of 1990
Certifications & Licensure
NY State Medical License 1991 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration Start of enrollment: 2006 May 01
- Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration Start of enrollment: 2008 Oct 01
- iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 35 citationsNatural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten
Ophthalmology. 2019-02-01 - 125 citationsProgression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.Tiarnan D L Keenan, Elvira Agrón, Amitha Domalpally, Traci E. Clemons, Freekje van Asten
Ophthalmology. 2018-12-01 - 27 citationsAnatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.Srinivas R. Sadda, Glenn L. Stoller, David S. Boyer, Barbara A Blodi, Howard Shapiro
Retina. 2010-10-01
Press Mentions
Topical Squalamine Offers Novel, Promising Therapy for nAMDDecember 11th, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
